DNAnexus: Accelerating the Future of Human Genetics and Precision Medicine The advancement of human genetics hinges on our ability to navigate and interpret vast, complex datasets. As research pushes the boundaries of discovery, from single-gene disorders to population-scale genomics, the challenges of data management, analysis, and collaboration have grown exponentially. DNAnexus is at the forefront of this evolution, providing a secure, scalable, and collaborative cloud-based platform designed to meet the unique needs of the global life sciences community. We are on a journey to democratize how researchers and clinicians work with clinico-genomic data, transforming it into actionable discoveries that improve patient outcomes. Unifying Complex, Multi-Modal Data at Scale DNAnexus leads the way in the management and analysis of multi-omics data to accelerate breakthroughs in precision medicine. Our Precision Health Data Cloud empowers life science organizations to seamlessly integrate complex genomic, transcriptomic, proteomic, clinical, and real-world datasets. This unified approach provides a holistic view of human biology, enabling researchers to uncover novel insights into disease mechanisms, identify new therapeutic targets, and power the next wave of drug discovery and development. The platform is built to handle data at scale, providing the robust foundation necessary for everything from rare disease analysis to large-scale population health studies. Fostering Secure Collaboration and Innovation Scientific progress is a collaborative endeavor. The DNAnexus platform provides a secure and collaborative environment where data can be combined and analyzed, fostering innovation without compromising on security or compliance. We enable this through solutions like Trusted Research Environments (TREs), which provide regulatory-grade spaces for dynamic collaboration and efficient, compliant submissions. Our unwavering commitment to the highest security standards ensures that sensitive data, privacy, and intellectual property are protected, allowing your teams to focus on what matters most: accelerating scientific discovery. Harnessing AI-Powered Analytics for Actionable Insights Built upon this foundation of integrated data and security, DNAnexus offers robust, AI-driven analytics to unlock the full potential of your research. By leveraging advanced AI and machine learning tools, our platform helps you move beyond raw data to find meaningful patterns and actionable insights. This empowers your organization to speed the journey from research to patient impact, simplifying regulatory compliance and driving innovations that improve healthcare for all. Engage with DNAnexus at ASHG 2025 to explore how our pioneering data analysis and management solutions can empower your research and help translate genetic discoveries into the future of precision health.
DIMA Biotechnology LLC
DIMA Biotechnology LLC accelerates cancer research through innovative membrane protein and monoclonal antibody discovery platforms. We specialize in producing full length, hard-to-express targets such as GPCRs, ion channels, and transporters et al. All our proteins are overexpressed in HEK293 cells to ensure high quality expression with correct PTMS. Our proprietary platforms include: – Synthetic Nanodisc, PeptiNanodisc, and Detergent-based systems: providing pure full length transmembrane proteins purified by affinity chromatography. – VLP (Virus Like Particles), MNP (Membrane Nano Particles), and Exosome-based systems—which present proteins in their native context but are not purified proteins. We offer over 500 Nanodisc products, with 300+ available in stock for next day delivery covering many GPCR and channel proteins. In antibody discovery, we provide both single B cell–derived rabbit mAbs and Nanobody development. We offer 5,000+ prevalidated recombinant mAb sequences targeting 500+ cancer relevant proteins, which are ready for out-licensing and testing. Additional IgG candidates can be screened within six weeks using proprietary B cell libraries. Our mammalian cell display platform supports antibody engineering services including humanization, affinity maturation, and functional screening. DIMA delivers integrated solutions from membrane protein production to antibody optimization to advance cancer research and therapeutic development.
Diamond Hoof Care
At Diamond Hoof Care, we understand the challenges of keeping your herd healthy and productive. That is why we deliver innovative, science-backed hoof care solutions that work. Our products, including Hoof-fit Gel, Repiderma, Hoof Sol Spray, and Hoof Sol Bath, simplify hoof care, reduce lameness, and improve herd performance. We go beyond products by offering practical advice, on-farm protocols, and hands-on support for farmers, veterinarians, and hoof trimmers. With over a decade of experience, we help clients boost animal welfare, save time, and achieve measurable results. Diamond Hoof Care is your partner in success.
Demeter Veterinary Services
Demeter remains a leader in swine health by proposing innovative solutions while prioritizing animal health and collaborating with producers to improve their profitability. A member of Swine Veterinary Partners, Demeter is part of a dynamic group of veterinarians, agronomists and nutritionists working together for industry sustainability.
Dawn Scientific
For over 40 years, Dawn Scientific has been serving the scientific community as a trusted manufacturer and distributor of laboratory equipment, chemicals, glassware, and scientific instruments. It was established in 1978 and incorporated in 1982 in New Jersey. Since then, Dawn Scientific has become renowned in the laboratory supply industry for innovation, customer satisfaction, and scientific excellence. With an ever-growing product portfolio and a global distribution network, we serve customers in the pharmaceutical, bio-pharma, chemical, cosmetic, and dietary supplement fields. Our mission is to provide laboratory solutions that are dependable, cost-effective, and unmatched when it comes to customer support, consultation, quality, and compliance.
Daiichi Sankyo, Inc.
With more than 100 years of scientific expertise and a presence in over 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation to realize our 2030 Vision to become an “Innovative Global Healthcare Company Contributing to the Sustainable Development of Society.”
Cyagen Biomodels LLC
Founded in 2006, Cyagen is a global provider of genetically modified rodent models and advanced CRO solutions for biomedical research and drug development. With more than 900 employees and research facilities covering 40,000 m², Cyagen supports researchers in over 100 countries and has contributed to more than 13,000 peer-reviewed publications, including in Cell, Nature, and Science. Headquartered in Santa Clara, California, Cyagen also operates subsidiaries in Japan and China, with major R&D and production centers in Guangzhou, Suzhou, and Gu’an. Combining expertise in cell and animal model generation with AI-driven discovery platforms, Cyagen provides scalable, reliable, one-stop solutions for basic research and preclinical drug development. Cyagen has developed several proprietary platforms to advance translational research, including HUGO-GT™ genomic humanized mouse models, the Rare Disease Data Center (RDDC) integrating genetic databases and AI tools
Cyanagen srl
Cyanagen Srl is an Italian biotech company founded in Bologna in 2003. The Company’s core business is designing, developing and manufacturing reagents for life sciences (RUO) and In Vitro Diagnostics (IVD). Mainly chemiluminescent substrates, fluorescent antibodies, magnetic beads, and DNA/RNA extraction kits. Our key technologies, covered by international patents, achieve outstanding sensitivity, stability, performance and ease of use. Thanks also to the OEM sales to global companies, Cyanagen is one of the world’s leading manufacturers of chemiluminescent substrates for Western blotting and ELISA/CLIA. Cyanagen also manufactures custom products according to clients’ specifications and starting materials in bulk sizes. Thanks to its experience IVD manufacturing, Cyanagen offers support in Analytical Validation Processes and for developing molecular diagnostics & biological assays. Cyanagen actively partners with EU universities and other companies for national and international calls. Certifications: ISO9001:2015 – ISO13485:2016.
Curia Global, Inc
Curia is a global Contract Development and Manufacturing Organization with over 30 years of experience successfully guiding clients through the complexities of drug discovery, development, and manufacturing to make treatments broadly accessible to patients. We offer services across Small Molecules, Generic APIs, and Biologics backed by deep scientific expertise and a robust global network of resources and capabilities. Our dedicated teams, combined with advanced technologies, enable us to be both flexible and scalable, accelerating the delivery of your product to patients. From curiosity to cure, we are your trusted ally, delivering every step to accelerate and sustain life-changing therapeutics. To learn more visit us at curiaglobal.com | Curia is a global CDMO with over 30 years of experience successfully guiding clients through the complexities of drug discovery, development, and manufacturing. Our Biologics services span discovery to clinical manufacturing, including clinical and commercial fill-finish services, for antibodies, recombinant proteins, mRNA therapeutics and many large molecule products. Curia’s expertise and agility deliver a best-in-class experience across discovery, drug substance and drug product development and manufacturing. From curiosity to cure, we are your trusted ally to accelerate life-changing therapeutics. To learn more, visit us at https://curiaglobal.com/biologics/
CuraScript SD by Evernorth
CuraScript SD provides integrated delivery solutions for the safe & efficient distribution of specialty pharmaceuticals & associated medical supplies. We’ve been caring for those who care for more than a quarter of a century by supplying biologics, branded drugs, generics, vaccines, infused medications and ancillary supportive care products to a wide range of medical providers.